GSRX Industries Inc. (GSRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -50.79 Million USD | -212.79% |
| 2018 | -16.23 Million USD | 37.74% |
| 2017 | -26.08 Million USD | -29526.93% |
| 2016 | -88.03 Thousand USD | -5.84% |
| 2015 | -83.17 Thousand USD | -4.51% |
| 2014 | -79.58 Thousand USD | -5.47% |
| 2013 | -75.45 Thousand USD | -7.91% |
| 2012 | -69.92 Thousand USD | -2.34% |
| 2011 | -68.32 Thousand USD | -7.91% |
| 2010 | -63.31 Thousand USD | -6.64% |
| 2009 | -59.37 Thousand USD | -17.39% |
| 2008 | -50.58 Thousand USD | -108.63% |
| 2007 | -24.24 Thousand USD | -468.04% |
| 2006 | -4268.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 Q3 | -2.97 Million USD | -1079.73% |
| 2020 Q2 | 303.92 Thousand USD | 22.44% |
| 2020 FY | - USD | 100.0% |
| 2020 Q1 | 248.22 Thousand USD | 101.85% |
| 2019 FY | -50.79 Million USD | -212.79% |
| 2019 Q4 | -13.39 Million USD | 56.0% |
| 2019 Q3 | -30.45 Million USD | -1287.13% |
| 2019 Q2 | -2.19 Million USD | 28.88% |
| 2019 Q1 | -3.08 Million USD | -19.12% |
| 2018 Q4 | -2.59 Million USD | -56.52% |
| 2018 Q2 | -1.33 Million USD | 84.36% |
| 2018 Q1 | -8.5 Million USD | 61.55% |
| 2018 FY | -16.23 Million USD | 37.74% |
| 2018 Q3 | -1.65 Million USD | -24.4% |
| 2017 Q3 | -659.44 Thousand USD | 80.0% |
| 2017 FY | -26.08 Million USD | -29526.93% |
| 2017 Q1 | -24.41 Thousand USD | -10.53% |
| 2017 Q4 | -22.12 Million USD | -3255.3% |
| 2017 Q2 | -3.29 Million USD | -13407.64% |
| 2016 FY | -88.03 Thousand USD | -5.84% |
| 2016 Q3 | -20.85 Thousand USD | 3.05% |
| 2016 Q4 | -22.08 Thousand USD | -5.92% |
| 2016 Q2 | -21.5 Thousand USD | 8.85% |
| 2016 Q1 | -23.59 Thousand USD | -12.58% |
| 2015 Q3 | -20 Thousand USD | -1.51% |
| 2015 FY | -83.17 Thousand USD | -4.51% |
| 2015 Q4 | -20.95 Thousand USD | -4.76% |
| 2015 Q2 | -19.7 Thousand USD | 12.42% |
| 2015 Q1 | -22.5 Thousand USD | -13.8% |
| 2014 FY | -79.58 Thousand USD | -5.47% |
| 2014 Q4 | -19.77 Thousand USD | -3.78% |
| 2014 Q1 | -21.32 Thousand USD | -16.94% |
| 2014 Q3 | -19.05 Thousand USD | 1.92% |
| 2014 Q2 | -19.42 Thousand USD | 8.92% |
| 2013 Q4 | -18.24 Thousand USD | -0.72% |
| 2013 Q3 | -18.11 Thousand USD | -2.73% |
| 2013 Q2 | -17.62 Thousand USD | 17.92% |
| 2013 Q1 | -21.47 Thousand USD | -29.49% |
| 2013 FY | -75.45 Thousand USD | -7.91% |
| 2012 Q3 | -18.94 Thousand USD | -29.94% |
| 2012 Q4 | -16.58 Thousand USD | 12.43% |
| 2012 Q1 | -19.82 Thousand USD | -12.2% |
| 2012 Q2 | -14.57 Thousand USD | 26.46% |
| 2012 FY | -69.92 Thousand USD | -2.34% |
| 2011 Q2 | -15.18 Thousand USD | 25.52% |
| 2011 Q3 | -15.09 Thousand USD | 0.59% |
| 2011 Q4 | -17.66 Thousand USD | -17.05% |
| 2011 FY | -68.32 Thousand USD | -7.91% |
| 2011 Q1 | -20.38 Thousand USD | -35.74% |
| 2010 Q1 | -19.97 Thousand USD | -48.43% |
| 2010 Q3 | -14.23 Thousand USD | -1.07% |
| 2010 Q4 | -15.01 Thousand USD | -5.48% |
| 2010 FY | -63.31 Thousand USD | -6.64% |
| 2010 Q2 | -14.08 Thousand USD | 29.48% |
| 2009 Q4 | -13.45 Thousand USD | 5.87% |
| 2009 Q2 | -13.67 Thousand USD | 23.8% |
| 2009 Q1 | -17.94 Thousand USD | -7.33% |
| 2009 FY | -59.37 Thousand USD | -17.39% |
| 2009 Q3 | -14.29 Thousand USD | -4.55% |
| 2008 Q4 | -16.72 Thousand USD | -23.14% |
| 2008 FY | -50.58 Thousand USD | -108.63% |
| 2008 Q1 | -11.48 Thousand USD | -76.16% |
| 2008 Q2 | -8796.00 USD | 23.41% |
| 2008 Q3 | -13.57 Thousand USD | -54.38% |
| 2007 Q2 | -6339.00 USD | -13.12% |
| 2007 FY | -24.24 Thousand USD | -468.04% |
| 2007 Q1 | -5604.00 USD | 0.0% |
| 2007 Q3 | -5782.00 USD | 8.79% |
| 2007 Q4 | -6519.00 USD | -12.75% |
| 2006 FY | -4268.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioQuest Corp. | -123.33 USD | 100.0% |
| High Sierra Technologies, Inc. | -323.95 Thousand USD | 100.0% |
| Instadose Pharma Corp. | - USD | NaN% |